HCA Healthcare (NYSE:HCA – Get Free Report) had its target price lowered by JPMorgan Chase & Co. from $313.00 to $265.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 7.56% from the company’s previous close.
HCA has been the topic of several other reports. Royal Bank of Canada reduced their target price on HCA Healthcare from $315.00 to $284.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 25th. Truist Financial dropped their price target on HCA Healthcare from $340.00 to $300.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Raymond James dropped their price target on HCA Healthcare from $320.00 to $280.00 and set an “outperform” rating for the company in a research note on Wednesday, October 25th. Cantor Fitzgerald restated an “overweight” rating and set a $315.00 price target on shares of HCA Healthcare in a research note on Thursday, September 14th. Finally, TheStreet lowered HCA Healthcare from a “b-” rating to a “c+” rating in a research note on Wednesday, October 25th. Two research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $296.59.
HCA Healthcare Stock Up 2.5 %
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Tuesday, October 24th. The company reported $3.91 earnings per share for the quarter, missing the consensus estimate of $3.97 by ($0.06). HCA Healthcare had a return on equity of 2,040.32% and a net margin of 9.05%. The business had revenue of $16.21 billion for the quarter, compared to analysts’ expectations of $15.77 billion. As a group, equities research analysts forecast that HCA Healthcare will post 18.18 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the company. Creative Planning grew its position in shares of HCA Healthcare by 25.4% in the 3rd quarter. Creative Planning now owns 36,273 shares of the company’s stock worth $8,922,000 after acquiring an additional 7,350 shares in the last quarter. Moneta Group Investment Advisors LLC grew its position in shares of HCA Healthcare by 24.2% in the 3rd quarter. Moneta Group Investment Advisors LLC now owns 2,740 shares of the company’s stock worth $674,000 after acquiring an additional 533 shares in the last quarter. Advisors Capital Management LLC grew its position in shares of HCA Healthcare by 199.1% in the 3rd quarter. Advisors Capital Management LLC now owns 3,661 shares of the company’s stock worth $901,000 after acquiring an additional 2,437 shares in the last quarter. Morgan Stanley boosted its position in HCA Healthcare by 1.4% during the 3rd quarter. Morgan Stanley now owns 2,150,009 shares of the company’s stock valued at $528,860,000 after purchasing an additional 30,072 shares during the period. Finally, Mercer Global Advisors Inc. ADV boosted its position in HCA Healthcare by 28.1% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 74,075 shares of the company’s stock valued at $18,221,000 after purchasing an additional 16,256 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Five stocks we like better than HCA Healthcare
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- S&P 500’s Whirlwind: Big gains, warning whispers & tactical moves
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 11/13 – 11/17
- Where to Find Earnings Call Transcripts
- 3 large caps with red hot RSIs with upside
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.